Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edo Vellenga

Showing results (41-50 of 246) with videos related to

Pageof 25
Sort By:
Experimental Hematology|January 29, 2005
Administration of low-dose cytarabine results in immediate S-phase arrest and subsequent activation of cell cycling in murine stem cellsKyrjon van Pelt, Gerald de Haan, Edo Vellenga, et al.
British Journal of Haematology|October 3, 2002
Myeloma clonotypic B cells are hampered in their ability to undergo B-cell differentiation in vitroJeroen E J Guikema, Edo Vellenga, Marleen H C Bakkus, et al.
European Journal of Cancer (Oxford, England : 1990)|December 20, 2008
The predictive value of interleukin-8 (IL-8) in hospitalised patients with fever and chemotherapy-induced neutropeniaYvonne H Tromp, Simon M G J Daenen, Wim J Sluiter, et al.
British Journal of Haematology|July 20, 2016
Overexpression of TP53 is associated with poor survival, but not with reduced response to hypomethylating agents in older patients with acute myeloid leukaemiaLieke H van der Helm, Gerbrig Berger, Arjan Diepstra, et al.
British Journal of Haematology|April 16, 2015
Effective targeting of primitive AML CD34+ cells by the second-generation proteasome inhibitor carfilzomibLieke H van der Helm, Matthieu C J Bosman, Jan J Schuringa, et al.
The Journal of Pathology|May 20, 2003
The attractive Achilles heel of germ cell tumours: an inherent sensitivity to apoptosis-inducing stimuliDiana C J Spierings, Elisabeth G E de Vries, Edo Vellenga, et al.
Molecular & Cellular Proteomics : MCP|December 13, 2012
A proteomics and transcriptomics approach to identify leukemic stem cell (LSC) markersFrancesco Bonardi, Fabrizia Fusetti, Patrick Deelen, et al.
Stem Cells (Dayton, Ohio)|January 27, 2005
Stem cell factor synergistically enhances thrombopoietin-induced STAT5 signaling in megakaryocyte progenitors through JAK2 and Src kinaseA Lyndsay Drayer, Arjen-Kars Boer, E Leonie Los, et al.
Leukemia & Lymphoma|August 3, 2002
The role of drug efflux pumps in acute myeloid leukemiaDorina M van der Kolk, Elisabeth G E de Vries, Michael Müller, et al.
British Journal of Haematology|January 14, 2004
CD27-triggering on primary plasma cell leukaemia cells has anti-apoptotic effects involving mitogen activated protein kinasesJeroen E J Guikema, Edo Vellenga, Wayel H Abdulahad, et al.
Pageof 25

Showing results (41-50 of 246) with videos related to

Sort By:
Pageof 25
Experimental Hematology|January 29, 2005
Administration of low-dose cytarabine results in immediate S-phase arrest and subsequent activation of cell cycling in murine stem cellsKyrjon van Pelt, Gerald de Haan, Edo Vellenga, et al.
British Journal of Haematology|October 3, 2002
Myeloma clonotypic B cells are hampered in their ability to undergo B-cell differentiation in vitroJeroen E J Guikema, Edo Vellenga, Marleen H C Bakkus, et al.
European Journal of Cancer (Oxford, England : 1990)|December 20, 2008
The predictive value of interleukin-8 (IL-8) in hospitalised patients with fever and chemotherapy-induced neutropeniaYvonne H Tromp, Simon M G J Daenen, Wim J Sluiter, et al.
British Journal of Haematology|July 20, 2016
Overexpression of TP53 is associated with poor survival, but not with reduced response to hypomethylating agents in older patients with acute myeloid leukaemiaLieke H van der Helm, Gerbrig Berger, Arjan Diepstra, et al.
British Journal of Haematology|April 16, 2015
Effective targeting of primitive AML CD34+ cells by the second-generation proteasome inhibitor carfilzomibLieke H van der Helm, Matthieu C J Bosman, Jan J Schuringa, et al.
The Journal of Pathology|May 20, 2003
The attractive Achilles heel of germ cell tumours: an inherent sensitivity to apoptosis-inducing stimuliDiana C J Spierings, Elisabeth G E de Vries, Edo Vellenga, et al.
Molecular & Cellular Proteomics : MCP|December 13, 2012
A proteomics and transcriptomics approach to identify leukemic stem cell (LSC) markersFrancesco Bonardi, Fabrizia Fusetti, Patrick Deelen, et al.
Stem Cells (Dayton, Ohio)|January 27, 2005
Stem cell factor synergistically enhances thrombopoietin-induced STAT5 signaling in megakaryocyte progenitors through JAK2 and Src kinaseA Lyndsay Drayer, Arjen-Kars Boer, E Leonie Los, et al.
Leukemia & Lymphoma|August 3, 2002
The role of drug efflux pumps in acute myeloid leukemiaDorina M van der Kolk, Elisabeth G E de Vries, Michael Müller, et al.
British Journal of Haematology|January 14, 2004
CD27-triggering on primary plasma cell leukaemia cells has anti-apoptotic effects involving mitogen activated protein kinasesJeroen E J Guikema, Edo Vellenga, Wayel H Abdulahad, et al.
Pageof 25